Cargando…
P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease
BACKGROUND: Over recent years, increasing evidence suggests a causal relationship between neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies, including Alzheimer’s disease (AD), and the ubiquitin–proteasome system (UPS) dysfunction detected in these patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245610/ https://www.ncbi.nlm.nih.gov/pubmed/37287063 http://dx.doi.org/10.1186/s13195-023-01258-x |
_version_ | 1785054896149495808 |
---|---|
author | Bianchi, Carolina Alvarez-Castelao, Beatriz Sebastián-Serrano, Álvaro Di Lauro, Caterina Soria-Tobar, Lucia Nicke, Annette Engel, Tobias Díaz-Hernández, Miguel |
author_facet | Bianchi, Carolina Alvarez-Castelao, Beatriz Sebastián-Serrano, Álvaro Di Lauro, Caterina Soria-Tobar, Lucia Nicke, Annette Engel, Tobias Díaz-Hernández, Miguel |
author_sort | Bianchi, Carolina |
collection | PubMed |
description | BACKGROUND: Over recent years, increasing evidence suggests a causal relationship between neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies, including Alzheimer’s disease (AD), and the ubiquitin–proteasome system (UPS) dysfunction detected in these patients. Nevertheless, the mechanisms underlying UPS failure and the factors involved remain poorly understood. Given that AD and tauopathies are associated with chronic neuroinflammation, here, we explore if ATP, one of the danger-associated molecules patterns (DAMPs) associated with neuroinflammation, impacts on AD-associated UPS dysfunction. METHODS: To evaluate if ATP may modulate the UPS via its selective P2X7 receptor, we combined in vitro and in vivo approaches using both pharmacological and genetic tools. We analyze postmortem samples from human AD patients and P301S mice, a mouse model that mimics pathology observed in AD patients, and those from the new transgenic mouse lines generated, such as P301S mice expressing the UPS reporter Ub(G76V)-YFP or P301S deficient of P2X7R. RESULTS: We describe for the first time that extracellular ATP-induced activation of the purinergic P2X7 receptor (P2X7R) downregulates the transcription of β5 and β1 proteasomal catalytic subunits via the PI3K/Akt/GSK3/Nfr2 pathway, leading to their deficient assembly into the 20S core proteasomal complex, resulting in a reduced proteasomal chymotrypsin-like and postglutamyl-like activities. Using UPS-reported mice (UbGFP mice), we identified neurons and microglial cells as the most sensitive cell linages to a P2X7R-mediated UPS regulation. In vivo pharmacological or genetic P2X7R blockade reverted the proteasomal impairment developed by P301S mice, which mimics that were detected in AD patients. Finally, the generation of P301S;UbGFP mice allowed us to identify those hippocampal cells more sensitive to UPS impairment and demonstrate that the pharmacological or genetic blockade of P2X7R promotes their survival. CONCLUSIONS: Our work demonstrates the sustained and aberrant activation of P2X7R caused by Tau-induced neuroinflammation contributes to the UPS dysfunction and subsequent neuronal death associated with AD, especially in the hippocampus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01258-x. |
format | Online Article Text |
id | pubmed-10245610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102456102023-06-08 P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease Bianchi, Carolina Alvarez-Castelao, Beatriz Sebastián-Serrano, Álvaro Di Lauro, Caterina Soria-Tobar, Lucia Nicke, Annette Engel, Tobias Díaz-Hernández, Miguel Alzheimers Res Ther Research BACKGROUND: Over recent years, increasing evidence suggests a causal relationship between neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies, including Alzheimer’s disease (AD), and the ubiquitin–proteasome system (UPS) dysfunction detected in these patients. Nevertheless, the mechanisms underlying UPS failure and the factors involved remain poorly understood. Given that AD and tauopathies are associated with chronic neuroinflammation, here, we explore if ATP, one of the danger-associated molecules patterns (DAMPs) associated with neuroinflammation, impacts on AD-associated UPS dysfunction. METHODS: To evaluate if ATP may modulate the UPS via its selective P2X7 receptor, we combined in vitro and in vivo approaches using both pharmacological and genetic tools. We analyze postmortem samples from human AD patients and P301S mice, a mouse model that mimics pathology observed in AD patients, and those from the new transgenic mouse lines generated, such as P301S mice expressing the UPS reporter Ub(G76V)-YFP or P301S deficient of P2X7R. RESULTS: We describe for the first time that extracellular ATP-induced activation of the purinergic P2X7 receptor (P2X7R) downregulates the transcription of β5 and β1 proteasomal catalytic subunits via the PI3K/Akt/GSK3/Nfr2 pathway, leading to their deficient assembly into the 20S core proteasomal complex, resulting in a reduced proteasomal chymotrypsin-like and postglutamyl-like activities. Using UPS-reported mice (UbGFP mice), we identified neurons and microglial cells as the most sensitive cell linages to a P2X7R-mediated UPS regulation. In vivo pharmacological or genetic P2X7R blockade reverted the proteasomal impairment developed by P301S mice, which mimics that were detected in AD patients. Finally, the generation of P301S;UbGFP mice allowed us to identify those hippocampal cells more sensitive to UPS impairment and demonstrate that the pharmacological or genetic blockade of P2X7R promotes their survival. CONCLUSIONS: Our work demonstrates the sustained and aberrant activation of P2X7R caused by Tau-induced neuroinflammation contributes to the UPS dysfunction and subsequent neuronal death associated with AD, especially in the hippocampus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01258-x. BioMed Central 2023-06-07 /pmc/articles/PMC10245610/ /pubmed/37287063 http://dx.doi.org/10.1186/s13195-023-01258-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bianchi, Carolina Alvarez-Castelao, Beatriz Sebastián-Serrano, Álvaro Di Lauro, Caterina Soria-Tobar, Lucia Nicke, Annette Engel, Tobias Díaz-Hernández, Miguel P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title | P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title_full | P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title_fullStr | P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title_full_unstemmed | P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title_short | P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease |
title_sort | p2x7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245610/ https://www.ncbi.nlm.nih.gov/pubmed/37287063 http://dx.doi.org/10.1186/s13195-023-01258-x |
work_keys_str_mv | AT bianchicarolina p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT alvarezcastelaobeatriz p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT sebastianserranoalvaro p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT dilaurocaterina p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT soriatobarlucia p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT nickeannette p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT engeltobias p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease AT diazhernandezmiguel p2x7receptorinhibitionamelioratesubiquitinproteasomesystemdysfunctionassociatedwithalzheimersdisease |